股本结构
单位：万股
| 公告日期 | 2025-11-06 | 2025-11-06 | 2025-07-31 | 2025-07-31 | 2025-05-08 | 2025-05-08 |
|---|---|---|---|---|---|---|
| 证券总股本 | 9850.93 | 7677.41 | 7608.79 | 7580.33 | 7555.33 | 7551.14 |
| 普通股本 | 4925.46 | 3838.70 | 3804.40 | 3790.16 | 3777.66 | 3775.57 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-10-31 | 2025-09-30 | 2025-07-24 | 2025-06-30 | 2025-04-23 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
，当前存托凭证比例为：0.5
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-06 | 9850.93 | 未披露 | 定期报告 | 2025-10-31 |
| 2025-11-06 | 7677.41 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common shares under ESPP
Issuance of common shares upon settlement of RSU awards
Exercise of 2022 USD Financing Warrants
Issuance of common shares upon conversion of loan principal
Exercise of stock options, net of shares withheld for exercise and tax
|
2025-09-30 |
| 2025-07-31 | 7608.79 | 未披露 | 定期报告 | 2025-07-24 |
| 2025-07-31 | 7580.33 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Exercise of stock options, net of shares withheld for exercise and tax
Issuance of common shares upon settlement of RSU awards
|
2025-06-30 |
| 2025-05-08 | 7555.33 | 未披露 | 定期报告 | 2025-04-23 |
| 2025-04-23 | 7555.15 | 未披露 | 定期报告 | 2025-04-16 |
| 2025-05-08 | 7551.14 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Issuance of common shares under employee share purchase plan ("ESPP")
Issuance of common shares upon settlement of restricted share unit ("RSU") awards, net of shares withheld for tax
Exercise of 2022 USD Financing Warrants
Exercise of stock options
|
2025-03-31 |
| 2025-03-06 | 7536.84 | 未披露 | 定期报告 | 2025-02-20 |
| 2025-03-06 | 7510.08 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of common shares and warrants, net of share issuance costs
Issuance of common shares upon settlement of restricted share unit awards, net of shares withheld for tax
Exchange of common shares for pre-funded warrants
Issuance of common shares upon conversion of loan principal
Exercise of 2022 USD Financing Warrants
Exercise of stock options, net of options withheld for tax
|
2024-12-31 |
| 2024-10-22 | 7333.17 | 未披露 | 定期报告 | 2024-10-21 |
| 2024-10-17 | 7332.17 | 未披露 | 定期报告 | 2024-10-17 |
| 2024-11-07 | 8159.05 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Issuance of common shares upon settlement of restricted share unit awards, net of shares withheld for tax
Issuance of common shares and warrants, net of share issuance costs
Exercise of stock options, net of options withheld for tax
|
2024-09-30 |
| 2024-08-12 | 8143.05 | 未披露 |
更多>>
Common stock offered 9,285,511 shares by the company
|
2024-08-12 |
| 2024-08-13 | 7214.50 | 未披露 | 定期报告 | 2024-07-24 |
| 2024-06-28 | 7207.51 | 未披露 | 定期报告 | 2024-06-25 |
| 2024-05-08 | 7187.24 | 未披露 | 定期报告 | 2024-04-23 |
| 2024-05-08 | 7116.37 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of common shares, net of share issuance costs
Issuance of common shares upon settlement of restricted share unit awards, net of shares withheld for tax
Exercise of 2022 USD Financing Warrants
Exercise of stock options
|
2024-03-31 |
| 2024-03-08 | 5800.10 | 未披露 |
更多>>
Common stock offered 16,666,667 shares by the company
|
2024-03-11 |
| 2024-02-28 | 4133.43 | 未披露 | 定期报告 | 2024-02-07 |
| 2024-02-28 | 4110.13 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Exercise of 2022 USD Financing Warrants
Issuance of common shares, net of share issuance costs
Exercise of stock options
Settlement of restricted share unit awards
|
2023-12-31 |
| 2023-11-02 | 4009.47 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Vesting of restricted share units
Exercise of 2022 USD Financing Warrants
Issuance of common shares, net of share issuance costs
Exercise of stock options
|
2023-09-30 |
| 2023-08-03 | 3971.69 | 未披露 | 定期报告 | 2023-07-24 |
| 2023-08-03 | 3880.72 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common shares, net of share issuance costs
Vesting of restricted share units
|
2023-06-30 |
| 2023-05-04 | 3859.53 | 未披露 | 定期报告 | 2023-04-25 |
| 2023-05-01 | 3859.37 | 未披露 | 定期报告 | 2023-04-20 |
| 2023-05-04 | 3829.01 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common shares, net of share issuance costs
Vesting of restricted stock units
|
2023-03-31 |
| 2023-03-09 | 3806.34 | 未披露 | 定期报告 | 2023-02-22 |
| 2023-03-09 | 3797.91 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of warrants
Settlement of restricted share unit awards
Issuance of common shares and warrants, net of share issuance costs
Exercise of stock options
|
2022-12-31 |
| 2022-11-10 | 3757.11 | 未披露 | 定期报告 | 2022-10-31 |
| 2022-11-10 | 3754.11 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common shares and warrants, net of issuance cost
Exercise of stock options
Settlement of restricted share unit awards
|
2022-09-30 |
| 2022-10-06 | 3550.48 | 未披露 | 定期报告 | 2022-09-29 |
| 2022-08-26 | 2847.25 | 未披露 |
更多>>
Mind Medicine (MindMed) Inc. announced that its previously announced 1-for-15 reverse share split of the Company’s common shares, par value $0.001, became effective after the close of markets on August 26, 2022, with trading expected to begin on a split-adjusted basis on the Nasdaq and the Neo Exchange Inc. (the “NEO”) at market open on August 29, 2022.
|
2022-08-29 |
| 2022-08-11 | 42708.81 | 未披露 | 定期报告 | 2022-08-03 |
| 2022-08-11 | 42668.92 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Exercise of warrants
Exercise of stock options
Settlement of restricted share unit awards
|
2022-06-30 |
| 2022-05-16 | 42244.45 | 未披露 | 定期报告 | 2022-05-03 |
| 2022-05-16 | 42240.18 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Multiple Voting Shares conversion to Subordinate Voting Shares
Exercise of warrants
Exercise of stock options
|
2022-03-31 |
| 2022-03-28 | 42188.48 | 未披露 | 定期报告 | 2022-02-28 |
| 2022-03-28 | 42144.87 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of Subordinate Voting Shares and warrants net of share issuance costs
Exchange of shares
Issuance of Subordinate Voting Shares for vested director compensation
Share-based settlement payment
Exercise of warrants
Exercise of stock options
Vesting of restricted stock units
|
2021-12-31 |
| 2021-11-12 | 42074.58 | 未披露 |
更多>>
From December 31, 2020 to September 30, 2021
Exchange of shares
Issuance of share capital net of share issuance costs
Share based payments
Warrants exercised
Options exercised
Shares issued for settlement of RSUs
HealthMode acquisition share consideration
|
2021-09-30 |
| 2021-08-13 | 36853.87 | 未披露 |
更多>>
From December 31, 2020 to June 30, 2021
Exchange of shares
Issuance of share capital net of share issuance costs
Share based payments
Warrants exercised
Options exercised
Shares issued for settlement of RSUs
|
2021-06-30 |
| 2021-04-28 | 34133.90 | 未披露 | 定期报告 | 2021-04-28 |
| 2021-04-09 | 34084.77 | 未披露 | 定期报告 | 2021-04-27 |
From June 30, 2025 to September 30, 2025
Issuance of common shares under ESPP
Issuance of common shares upon settlement of RSU awards
Exercise of 2022 USD Financing Warrants
Issuance of common shares upon conversion of loan principal
Exercise of stock options, net of shares withheld for exercise and tax
From March 31, 2025 to June 30, 2025
Exercise of stock options, net of shares withheld for exercise and tax
Issuance of common shares upon settlement of RSU awards
From December 31, 2024 to March 31, 2025
Issuance of common shares under employee share purchase plan ("ESPP")
Issuance of common shares upon settlement of restricted share unit ("RSU") awards, net of shares withheld for tax
Exercise of 2022 USD Financing Warrants
Exercise of stock options
From December 31, 2023 to December 31, 2024
Issuance of common shares and warrants, net of share issuance costs
Issuance of common shares upon settlement of restricted share unit awards, net of shares withheld for tax
Exchange of common shares for pre-funded warrants
Issuance of common shares upon conversion of loan principal
Exercise of 2022 USD Financing Warrants
Exercise of stock options, net of options withheld for tax
From June 30, 2024 to September 30, 2024
Issuance of common shares upon settlement of restricted share unit awards, net of shares withheld for tax
Issuance of common shares and warrants, net of share issuance costs
Exercise of stock options, net of options withheld for tax
Common stock offered 9,285,511 shares by the company
From December 31, 2023 to March 31, 2024
Issuance of common shares, net of share issuance costs
Issuance of common shares upon settlement of restricted share unit awards, net of shares withheld for tax
Exercise of 2022 USD Financing Warrants
Exercise of stock options
Common stock offered 16,666,667 shares by the company
From December 31, 2022 to December 31, 2023
Exercise of 2022 USD Financing Warrants
Issuance of common shares, net of share issuance costs
Exercise of stock options
Settlement of restricted share unit awards
From June 30, 2023 to September 30, 2023
Vesting of restricted share units
Exercise of 2022 USD Financing Warrants
Issuance of common shares, net of share issuance costs
Exercise of stock options
From March 31, 2023 to June 30, 2023
Issuance of common shares, net of share issuance costs
Vesting of restricted share units
From December 31, 2022 to March 31, 2023
Issuance of common shares, net of share issuance costs
Vesting of restricted stock units
From December 31, 2021 to December 31, 2022
Exercise of warrants
Settlement of restricted share unit awards
Issuance of common shares and warrants, net of share issuance costs
Exercise of stock options
From June 30, 2022 to September 30, 2022
Issuance of common shares and warrants, net of issuance cost
Exercise of stock options
Settlement of restricted share unit awards
Mind Medicine (MindMed) Inc. announced that its previously announced 1-for-15 reverse share split of the Company’s common shares, par value $0.001, became effective after the close of markets on August 26, 2022, with trading expected to begin on a split-adjusted basis on the Nasdaq and the Neo Exchange Inc. (the “NEO”) at market open on August 29, 2022.
From March 31, 2022 to June 30, 2022
Exercise of warrants
Exercise of stock options
Settlement of restricted share unit awards
From December 31, 2021 to March 31, 2022
Multiple Voting Shares conversion to Subordinate Voting Shares
Exercise of warrants
Exercise of stock options
From December 31, 2020 to December 31, 2021
Issuance of Subordinate Voting Shares and warrants net of share issuance costs
Exchange of shares
Issuance of Subordinate Voting Shares for vested director compensation
Share-based settlement payment
Exercise of warrants
Exercise of stock options
Vesting of restricted stock units
From December 31, 2020 to September 30, 2021
Exchange of shares
Issuance of share capital net of share issuance costs
Share based payments
Warrants exercised
Options exercised
Shares issued for settlement of RSUs
HealthMode acquisition share consideration
From December 31, 2020 to June 30, 2021
Exchange of shares
Issuance of share capital net of share issuance costs
Share based payments
Warrants exercised
Options exercised
Shares issued for settlement of RSUs